share_log
Breakings ·  Dec 3 21:01
Relay Therapeutics Inc - FDA Recommends Nda for Fgfr2-Driven Cca Followed by Supplemental Nda
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment